Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

74 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Thirty-Day Readmissions Are Largely Not Preventable in Patients With Cirrhosis.
Orman ES, Desai AP, Ghabril MS, Nephew LD, Patidar KR, Holden J, Samala NR, Gawrieh S, Vuppalanchi R, Sozio M, Lacerda M, Vilar-Gomez E, Lammert C, Liangpunsakul S, Crabb D, Masuoka H, Dakhoul L, Pan M, Gao S, Chalasani N. Orman ES, et al. Am J Gastroenterol. 2024 Feb 1;119(2):287-296. doi: 10.14309/ajg.0000000000002455. Epub 2023 Sep 27. Am J Gastroenterol. 2024. PMID: 37543729
Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease: A Multi-National Cohort Study.
Vilar-Gomez E, Calzadilla-Bertot L, Wai-Sun Wong V, Castellanos M, Aller-de la Fuente R, Metwally M, Eslam M, Gonzalez-Fabian L, Alvarez-Quiñones Sanz M, Conde-Martin AF, De Boer B, McLeod D, Hung Chan AW, Chalasani N, George J, Adams LA, Romero-Gomez M. Vilar-Gomez E, et al. Gastroenterology. 2018 Aug;155(2):443-457.e17. doi: 10.1053/j.gastro.2018.04.034. Epub 2018 May 5. Gastroenterology. 2018. PMID: 29733831 Free article.
Post hoc analyses of surrogate markers of non-alcoholic fatty liver disease (NAFLD) and liver fibrosis in patients with type 2 diabetes in a digitally supported continuous care intervention: an open-label, non-randomised controlled study.
Vilar-Gomez E, Athinarayanan SJ, Adams RN, Hallberg SJ, Bhanpuri NH, McKenzie AL, Campbell WW, McCarter JP, Phinney SD, Volek JS, Chalasani N. Vilar-Gomez E, et al. BMJ Open. 2019 Feb 25;9(2):e023597. doi: 10.1136/bmjopen-2018-023597. BMJ Open. 2019. PMID: 30803948 Free PMC article.
Early predictors of outcomes of hospitalization for cirrhosis and assessment of the impact of race and ethnicity at safety-net hospitals.
Mukthinuthalapati VVPK, Akinyeye S, Fricker ZP, Syed M, Orman ES, Nephew L, Vilar-Gomez E, Slaven J, Chalasani N, Balakrishnan M, Long MT, Attar BM, Ghabril M. Mukthinuthalapati VVPK, et al. PLoS One. 2019 Mar 6;14(3):e0211811. doi: 10.1371/journal.pone.0211811. eCollection 2019. PLoS One. 2019. PMID: 30840670 Free PMC article.
Reply.
Vilar-Gomez E, Chalasani N. Vilar-Gomez E, et al. Hepatology. 2019 Aug;70(2):752. doi: 10.1002/hep.30605. Hepatology. 2019. PMID: 30854668 No abstract available.
74 results